Latest Breaking News On - Chris mutz - Page 1 : comparemela.com
FDA to Review sNDA for Purified Cortrophin Gel for Multiple Indications
neurologyadvisor.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from neurologyadvisor.com Daily Mail and Mail on Sunday newspapers.
FDA to Review sNDA for Purified Cortrophin Gel for Multiple Indications
empr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from empr.com Daily Mail and Mail on Sunday newspapers.
FDA to Review sNDA for Purified Cortrophin Gel for Multiple Indications
renalandurologynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from renalandurologynews.com Daily Mail and Mail on Sunday newspapers.
ANI Pharmaceuticals Announces FDA Acceptance of Purified Cortrophin® Gel Supplemental New Drug Application for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis, and Nephrotic Syndrome - Press Release
wiredprnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wiredprnews.com Daily Mail and Mail on Sunday newspapers.
Operator
Good day everyone, and welcome to today s ANI Pharmaceuticals First Quarter 2021 Earnings Release Call. [Operator Instructions]
It s now my pleasure to turn the conference over to Lisa Wilson. Please go ahead.
Lisa M. Wilson
Investor Relations
Thank you, operator. Welcome to ANI Pharmaceuticals Q1 2021 earnings results call. This is Lisa Wilson of In-Site Communications, Investor Relations for ANI. With me on today s call are Nikhil Lalwani, President and Chief Executive Officer; and Stephen Carey, Chief Financial Officer of ANI. You can also access the webcast of this call through the Investors section of the ANI website at anipharmaceuticals.com.